DUBLIN, March 14 (Reuters) - Ireland's National Immunisation
Advisory Committee recommended the temporary deferral of
AstraZeneca's COVID-19 vaccine on Sunday following new
information received from the Norwegian Medicines Agency, the
country's health ministry said.
Three health workers in Norway who had recently received the
AstraZeneca COVID-19 vaccine are being treated in
hospital for bleeding, blood clots and a low count of blood
platelets, its health authorities said on Saturday.
AstraZeneca vaccinations make up almost 20% of the 570,000
shots administered in Ireland, mainly to healthcare workers
after its use was not initially recommended for those over 70.
The advisory committee said it acted as a precaution, pending
the receipt of more information and would meet later on Sunday.
(Reporting by Padraic Halpin, editing by Louise Heavens)